Q86WV6 (STING_HUMAN) Homo sapiens (Human)

Stimulator of interferon genes protein UniProtKBInterProSTRINGInteractive Modelling

379 aa; Sequence (Fasta)

Available Structures

93 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human STING in complex with 3',3'-c-di-(2'F,2'd<carba>AMP) Heteromer
Q12306;
154-340
K43;
Assess
Phosphorylated STING in complex with IRF-3 CTD Heteromer
Q14653;
359-379
Assess
Crystal structure of STING CTT in complex with TBK1 Heteromer
Q9WUN2;
366-379
BX7;
Assess
Crystal structure of STING CTD in complex with TBK1 Heteromer
Q9UHD2;
368-379
BX7;
Assess
phospho-STING binding to adaptor protein complex-1 Heteromer
P22892; P35585; P84077; Q10567; Q96PC3;
359-367
GTP;MG;
Assess
Structure of Stimulator of interferon genes/ligand complexhomo-8-mer4-337
1SY;
Assess
Human STING bound to both cGAMP and 1-[(2-chloro-6-fluorophenyl)methyl]-3,3-dimethyl-2-oxo-N-[(2,4,…homo-4-mer3-335
9IM;1SY;
Assess
Cryo-EM structure of STING oligomer bound to cGAMP and NVS-STG2homo-4-mer3-335
1SY;Y6H;
Assess
Cryo-EM structure of STING oligomer bound to cGAMP, NVS-STG2 and C53homo-4-mer4-335
Y6H;1SY;9IM;
Assess
Structure of STING SAVI-related mutant V147Lhomo-2-mer3-337
Assess
Cryo-EM structure of full-length human STING in the apo statehomo-2-mer4-336
Assess
human STING With agonist HB3089homo-2-mer5-337
WJ6;
Assess
Crystal structure of ligand free human STING CTDhomo-2-mer151-343
CA;
Assess
Crystal structure of human STING CTD complex with C-di-GMPhomo-2-mer151-343
CA;C2E;
Assess
human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-[(2-naphthyloxy)methyl]phenyl)-AMPhomo-2-mer147-338
KXD;
Assess
Crystal structure of STING CTD complex with c-di-GMPhomo-2-mer152-343
C2E;CA;
Assess
human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-(2-naphthyl)phenyl)-AMPhomo-2-mer147-338
KWF;
Assess
Crystal structure of STING CTDhomo-2-mer152-343
Assess
amidobenzimidazole (ABZI) STING agonistshomo-2-mer153-343
CA;HGJ;
Assess
Linked amidobenzimidazole STING agonisthomo-2-mer153-343
HG4;CA;
Assess
Crystal structure of hSTING with an agonist (SHR169224)homo-2-mer153-343
CA;GD2;
Assess
Crystal structure of hSTING with the agonist, SHR171032homo-2-mer153-343
CA;GC0;
Assess
Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-2'd<carba>GMP)homo-2-mer154-343
JLU;
Assess
Human REF STING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)]homo-2-mer151-340
GOL;PWB;
Assess
Crystal structure of STING complex with Cyclic di-GMP.homo-2-mer154-343
C2E;
Assess
human STING in complex with 2',3'-cyclic-GMP-7-deazaphenyl-AMPhomo-2-mer151-339
OK6;
Assess
ERIS/STING in complex with ligandhomo-2-mer153-340
C2E;MG;
Assess
human STING with diABZI agonist 15homo-2-mer153-339
WWU;
Assess
Crystal structure of human wild type STING in complex with 2'-3'-cyclic-GMP-7-deaza-AMPhomo-2-mer150-336
KT2;
Assess
human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-biphenylyl)-AMPhomo-2-mer151-337
KWO;
Assess
Crystal structure of human STING complexed with compound BSP16homo-2-mer153-339
A9X;
Assess
Human wtSTING in complex with 3',3'-c-di-AMPhomo-2-mer154-340
2BA;
Assess
hSTING mutant R232K in complex with 2',3'-cGAMPhomo-2-mer153-339
1SY;
Assess
human STING with agonist XMT-1616homo-2-mer153-338
WX8;
Assess
Crystal structure of ERIS/STINGhomo-2-mer151-336
EPE;
Assess
Crystal structure of human STING complexed with compound BSP17homo-2-mer154-339
A8A;
Assess
Crystal structure of STING in complex with cGAMPhomo-2-mer152-336
1SY;
Assess
Crystal structure of human STING in complex with 3'2'-cGAMPhomo-2-mer152-336
4UR;
Assess
Crystal structure of human STING ectodomain in complex with BI 7446, a potent cyclic dinucleotide S…homo-2-mer152-336
W78;
Assess
Structure of hSTING in complex with novel carbocyclic pyrimidine CDN-2homo-2-mer152-336
X5D;
Assess
Structure of hSTING in complex with novel carbocyclic pyrimidine CDN 1homo-2-mer152-336
X5J;
Assess
Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STINGhomo-2-mer154-338
Assess
Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-<carba>IMP)homo-2-mer153-337
K1L;
Assess
Crystal structure of human STING in complex with 3',3'-c-(2'dAMP-2'F,2'd<carba>AMP)homo-2-mer154-338
KAX;
Assess
Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP(S)-2'F,2'd<carba>AMP(S))homo-2-mer154-338
KZA;
Assess
Structure of hSTING in complex with novel carbocyclic pyrimidine CDN-3homo-2-mer152-335
X4M;
Assess
Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(2',5')p]homo-2-mer155-338
PO4;1YC;
Assess
Human Stimulator of Interferon Geneshomo-2-mer154-337
2BA;IMD;GOL;
Assess
hSTING in complex with 3',3'-c-di-araAMPhomo-2-mer153-336
V7E;
Assess
Crystal structure of human STING in complex with MD1193homo-2-mer154-337
98F;
Assess
Human wtSTING in complex with 3',3'-c-(2'FdAMP-2'FdAMP)homo-2-mer153-336
M8T;
Assess
Crystal structure of STING REF variant in complex with E7766homo-2-mer155-338
V5V;EDO;
Assess
Human wtSTING in complex with 3',3'-cGAMPhomo-2-mer154-337
4BW;
Assess
Crystal Structure of human STING bound to c-di-GMPhomo-2-mer155-337
C2E;CA;
Assess
Crystal structure of human STING apoprotein (G230A, H232R, R293Q)homo-2-mer155-337
CA;
Assess
Crystal Structure of Human STING CTD complex with SR-717homo-2-mer155-337
V67;GOL;EDO;
Assess
Crystal structure of ligand free human STINGhomo-2-mer155-337
CA;
Assess
Crystal structure of STING CTD in complex with BDW-OHhomo-2-mer154-336
YGI;
Assess
Crystal structure of STING CTD in complex with 2'3'-cGAMPhomo-2-mer154-336
1SY;
Assess
Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(3',5')p]homo-2-mer155-337
1SY;
Assess
Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-2'F,2'd<carba>AMP)homo-2-mer154-336
K1C;
Assess
Structure of human STING in complex with MK-1454homo-2-mer154-336
ZEV;
Assess
Crystal structure of STING in complex with E7766homo-2-mer155-337
V5V;
Assess
Human wtSTING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)]homo-2-mer154-336
PWB;
Assess
Crystal structure of human STING in complex with 3'3'-c-(2'F,2'dA-isonucA)MPhomo-2-mer154-336
8SC;
Assess
Human wtSTING in complex with 3'3'-c-di-GMPhomo-2-mer154-336
C2E;
Assess
Structure of the human STING receptor bound to 2'3'-cUAhomo-2-mer154-336
ZNT;
Assess
Human wtSTING in complex with 2',2'-difluoro-3',3'-c-di-GMPhomo-2-mer154-336
GGF;
Assess
Crystal structure of human wild type STING in complex with 2'3'-cyclic-GMP-2'F-2'dAMPhomo-2-mer154-336
KT8;
Assess
Crystal structure of human STING in complex with the agonist MD1203homo-2-mer154-336
VZ6;
Assess
Crystal structure of human STING in complex with the agonist MD1202Dhomo-2-mer154-336
WY8;
Assess
Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 1homo-2-mer155-336
K5P;CA;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 6homo-2-mer155-336
QBG;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 9homo-2-mer155-336
QB1;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 11homo-2-mer155-336
QBA;
Assess
Human Stimulator of Interferon Geneshomo-2-mer154-335
1SY;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 10homo-2-mer155-336
QB7;
Assess
Crystal structure of hSTING in complex with c[2',3'-(ribo-2'-G, xylo-3'-A)-MP](RJ244)homo-2-mer155-336
9UR;
Assess
Crystal structure of hSTING in complex with c[2',3'-(ara-2'-G, ribo-3'-A)-MP] (RJ242)homo-2-mer155-336
9UH;
Assess
Stimulator of Interferon Genes Humanhomo-2-mer154-335
2BA;
Assess
Human wtSTING in complex with 2',2'-difluoro-3',3'-cGAMPhomo-2-mer154-335
OOE;
Assess
WT STING in complex with 3',3'-c-di[2'FdAM(PS)]homo-2-mer154-335
R4T;
Assess
Crystal structure of hSTING(group2) in complex with DMXAAhomo-2-mer155-335
1YE;
Assess
Crystal structure of human STING R232 in complex with compound 11homo-2-mer155-335
B7L;
Assess
Crystal structure of hSTING(S162A/G230I/Q266I) in complex with DMXAAhomo-2-mer155-335
1YE;SO4;
Assess
Crystal structure of hSTING(S162A/Q266I) in complex with DMXAAhomo-2-mer155-335
1YE;SO4;
Assess
Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 18homo-2-mer155-335
K5S;CA;
Assess
Crystal structure of hSTING(G230I) in complex with DMXAAhomo-2-mer155-335
1YE;
Assess
Crystal structure of human STING in complex with ADU-S100monomer153-338
GJF;CA;NA;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 12monomer155-337
QBD;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 3monomer155-336
QAV;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound MSA-2monomer155-336
QAD;
Assess
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 4monomer155-335
QBJ;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7sii.1.Ahomo-4-mer0.733-335
9IM;99.71
Assess
8gsz.1.Ahomo-2-mer0.663-337
99.74
Assess